甲氧苄啶-磺胺甲恶唑所致的继发性血小板减少症。
Thrombocytopenia secondary to trimethoprim-sulfamethoxazole.
作者信息
Hagen M D, White R D
出版信息
South Med J. 1983 Apr;76(4):503. doi: 10.1097/00007611-198304000-00025.
Abstract
Two patients had severe thrombocytopenia while taking trimethoprim-sulfamethoxazole. The mechanism is uncertain, but probably is related to drug interference with folate metabolism. Recovery can usually be expected upon withdrawal of the medication and institution of folic acid therapy.
摘要
两名患者在服用复方新诺明时出现严重血小板减少症。其机制尚不清楚，但可能与药物干扰叶酸代谢有关。停药并开始叶酸治疗后通常有望康复。
Zotero 插件